Medgadget (blog)Stem Cell Market Outlook to 2025 – Medipost, Pharmicell, Holostem Terapie Avanzate, Mesoblast, US Stem Cell …Medgadget (blog)Stem cell therapy is a technique which uses stem cells for the treatment of various disorders. Stem cell ther… Continue reading
FierceBiotechGene therapy startup MeiraGTx files for $86M IPOFierceBiotechMeiraGTx has filed for an $86 million IPO to advance a handful of gene therapies into and through clinical trials. The transatlantic biotech is initially targeting inherited reti… Continue reading
MimiVax to Present Interim Phase II Trial Data on Multi-focal Immunotherapy SurVaxM for the Treatment of …GlobeNewswire (press release)SurVaxM is an immunotherapy that was discovered at Roswell Park Comprehensive Cancer Center and is being developed … Continue reading
StockNewsGazette |
CRISPR Therapeutics Announces Presentations at the ASGCT 21st Annual Meeting
GlobeNewswire (press release) ZUG, Switzerland and CAMBRIDGE, Mass., May 15, 2018 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that … Premarket analyst action – healthcareSeeking Alpha Analyst Activity – Chardan Capital Raises Its Price Target On NASDAQ:CRSP – CRISPR Therapeutics (NASDAQ …Market Exclusive CRISPR Therapeutics AG (CRSP) vs. INSYS Therapeutics, Inc. (INSY): Breaking Down the Biotechnology Industry’s …StockNewsGazette |
Seeking Alpha |
Bluebird Bio Expands On Partnership To Take A Lead In Immuno-Oncology
Seeking Alpha Bluebird Bio expands license agreement for two additional TCR targets. There is a need for TCRs, because CAR–T are strong but can’t target tumor proteins that are inside of cells only those that are expressed on the cell’s surface. Bluebird Bio will … bluebird bio expands US$1bn deal with MediGeneEuropean Biotechnology |